Duloxetine for subacute pain management after total knee arthroplasty: Should we write it off or reevaluate?

Anesthesiology

Volumn 125, Issue 3, 2016, Pages 454-456

  Jacobs, Michael B ^a,b   Cohen, Steven P ^b,c  

^a Walter Reed National Military Medical Center   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE;

ANALGESIA; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG EFFICACY; EDITORIAL; FUNCTIONAL STATUS; HUMAN; POSTOPERATIVE PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TOTAL KNEE ARTHROPLASTY; KNEE REPLACEMENT; PAIN MEASUREMENT;

ARTHROPLASTY, REPLACEMENT, KNEE; DULOXETINE HYDROCHLORIDE; HUMANS; PAIN MEASUREMENT; PAIN, POSTOPERATIVE;

EID: 84978153369     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000001229     Document Type: Editorial

References (18)

1. Bekelman JE, Li Y, Gross CP: Scope and impact of financial conflicts of interest in biomedical research: A systematic review. JAMA 2003; 289:454-65
2. Chappell AS, Desaiah D, Liu-Seifert H, Zhang S, Skljarevski V, Belenkov Y, Brown JP: A double-blind, randomized, placebocontrolled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee. Pain Pract 2011; 11:33-41
3. Chappell AS, Ossanna MJ, Liu-Seifert H, Iyengar S, Skljarevski V, Li LC, Bennett RM, Collins H. Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: A 13-week, randomized, placebo-controlled trial. Pain 2009; 146:253-60
4. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, Haythornthwaite JA, Jensen MP, Kerns RD, Ader DN, Brandenburg N, Burke LB, Cella D, Chandler J, Cowan P, Dimitrova R, Dionne R, Hertz S, Jadad AR, Katz NP, Kehlet H, Kramer LD, Manning DC, McCormick C, McDermott MP, McQuay HJ, Patel S, Porter L, Quessy S, Rappaport BA, Rauschkolb C, Revicki DA, Rothman M, Schmader KE, Stacey BR, Stauffer JW, von Stein T, White RE, Witter J, Zavisic S. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 2008; 9:105-21
5. YaDeau JT, Brummett CM, Mayman DJ, Lin Y, Goytizolo EA, Padgett DE, Alexiades MM, Kahn RL, Jules-Elysee KM, Fields KG, Goon AK, Gadulov Y, Westrich G. Duloxetine and subacute pain after knee arthroplasty when added to a multimodal analgesic regimen: A randomized, placebo-controlled, triple-blinded trial. Anesthesiolo gy 2016; 125:561-72
6. Ho KY, Tay W, Yeo MC, Liu H, Yeo SJ, Chia SL, Lo NN: Duloxetine reduces morphine requirements after knee replacement surgery. Br J Anaesth 2010; 105:371-6
7. Hyer L, Scott C, Mullen CM, McKenzie LC, Robinson JS: Randomized double-blind placebo trial of duloxetine in perioperative spine patients. J Opioid Manag 2015; 11:147-55
8. Messier SP, Mihalko SL, Legault C, Miller GD, Nicklas BJ, DeVita P, Beavers DP, Hunter DJ, Lyles MF, Eckstein F, Williamson JD, Carr JJ, Guermazi A, Loeser RF: Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: The IDEA randomized clinical trial. JAMA 2013; 310:1263-73
9. Most Frequent Operating Room Procedures Performed in U.S. Hospitals, 2003-2012. 2014. Available at: https://www.hcup-us.ahrq.gov/reports/statbriefs/sb186-Operating-Room-Procedures-United-States-2012.jsp. Accessed May 9, 2016
10. Cram P, Lu X, Kates SL, Singh JA, Li Y, Wolf BR: Total knee arthroplasty volume, utilization, and outcomes among Medicare beneficiaries, 1991-2010. JAMA 2012; 308: 1227-36
11. Losina E, Walensky RP, Kessler CL, Emrani PS, Reichmann WM, Wright EA, Holt HL, Solomon DH, Yelin E, Paltiel AD, Katz JN: Cost-effectiveness of total knee arthroplasty in the United States: Patient risk and hospital volume. Arch Intern Med 2009; 169:1113-21; discussion 1121-2
12. Westby MD: Rehabilitation and total joint arthroplasty. Clin Geriatr Med 2012; 28:489-508
13. Mou J, Paillard F, Turnbull B, Trudeau J, Stoker M, Katz NP: Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: A meta-analysis of the Qutenza Clinical Trials Database. Pain 2013; 154:1632-9
14. Berde CB, Walco GA, Krane EJ, Anand KJ, Aranda JV, Craig KD, Dampier CD, Finkel JC, Grabois M, Johnston C, Lantos J, Lebel A, Maxwell LG, McGrath P, Oberlander TF, Schanberg LE, Stevens B, Taddio A, von Baeyer CL, Yaster M, Zempsky WT: Pediatric analgesic clinical trial designs, measures, and extrapolation: Report of an FDA scientific workshop. Pediatrics 2012; 129:354-64
15. Rathmell JP, Kehlet H. Do we have the tools to prevent phantom limb pain? Anesthesiolo gy 2011; 114:1021-4
16. Lunn MP, Hughes RA, Wiffen PJ: Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev 2014; 1:CD007115
17. Haroutiunian S, Nikolajsen L, Finnerup NB, Jensen TS: The neuropathic component in persistent postsurgical pain: A systematic literature review. Pain 2013; 154:95-102
18. Frakes EP, Risser RC, Ball TD, Hochberg MC, Wohlreich MM: Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: Results of a randomized, double-blind, placebo-controlled trial. Curr Med Res Opin 2011; 27:2361-72